3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 3
2
Phase 2
2
Phase 4
1
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thromboembolism
4
Neoplasms
4
Venous Thrombosis
2
Carcinoma, Non-Small-Cell Lung
2
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Malignant Female Reproductive System Neoplasm
1
Abdominal Neoplasms
1
Interventions
apixaban
5
Dalteparin
5
edoxaban
2
bemiparin
2
abelacimab
2
Tinzaparin
2
Nadroparin
2
MAA868
2
Heparin, Low-Molecular-Weight
2
Enoxaparin
2
reviparin
1
isoquercitrin
1
certoparin
1
atezolizumab
1
acarboxyprothrombin
1
Warfarin
1
Rivaroxaban
1
Phenprocoumon
1
Intermittent Pneumatic Compression Devices
1
Fondaparinux
1
Dabigatran
1
Bevacizumab
1
Acenocoumarol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Venous Thrombosis
×
Enoxaparin
×
Clear all
NCT04462003
2020-07-08
DVT
Beni-Suef University
Phase 3
Unknown
100 enrolled
NCT01164046
2014-12-03
Longheva
University Medical Center Groningen
Phase 3
Terminated
56 enrolled